DermTopic: Psoriasis

Filter Your Results

 

News

 

Abbvie's Risankizumab Performs Well in Three Phase Three Pso…

Top-line results from three pivotal Phase 3 clinical trials show that  risankizumab, an investigational interleukin…

FDA Approves Janssen’s Golimumab for PsA, AS

  The FDA approved Janssen’s SIMPONI ARIA (golimumab) for the treatment of adults with active psoriat…

Ortho Dermatologics: Long-term Efficacy Data for Siliq

Siliq™ (brodalumab) injection provided sustained high levels of skin clearance (PASI 100) over more than two years…

FDA Approves Stelara for Treatment of Adolescents with Moder…

The FDA approved an expanded indication for Janssen Biotech, Inc.'s Stelara (ustekinumab) for the treatment of adole…

Penn Derm Awarded $8.6M to Study Home Versus In-Office Photo…

A research team at the University of Pennsylvania will receive $8.6 million to study the effectiveness of home-based pho…

Two-Year Data: TREMFYA™ (guselkumab) Achieves Consistent R…

New longer-term data from the open-label extension of the VOYAGE 1 trial demonstrate consistent rates of skin clearance …

IPC, Others Call for Creation of Worldwide Psoriasis Databas…

A new report calls for the creation of a web-based Global Psoriasis Atlas (GPA) database that will document the prevalen…

Five-Year Data Show Sustained Efficacy, Safety for Cosentyx

Novartis’ IL-17 blocker Cosentyx® (secukinumab) maintains PASI 90 and PASI 100 response rates at five yea…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.